ChemoCentryx Inc(CCXI:US)
Market Cap$593.76M
Key Metrics
Price$10.66
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$410.1K
Total Assets$419.11M
Net Assets$402.96M
Total Debt$0
Key Metrics
Price$10.66
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$410.1K
Total Assets$419.11M
Net Assets$402.96M
Total Debt$0
Financials

| Name | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $11.76M | $5.46M | $2.29M | $17.69M |
Cost of Revenue | - | - | $803K | $205K | $302K | - |
Gross Profit | - | - | $10.96M | $5.25M | $1.99M | - |
| $373.67K | $50.93K | $42.53M | $43.49M | $42.04M | $39.49M | |
| Research and Development | - | - | $14.36M | $17.48M | $18.77M | $19.95M |
| Selling, General, and Administrative | $373.67K | $50.93K | $28.18M | $26.01M | $23.29M | $19.6M |
| Other Operating Expenses | - | - | - | - | -$28K | -$52K |
Operating Income | -$373.67K | -$50.93K | -$31.57M | -$38.23M | -$40.05M | -$21.8M |
| $3.55M | - | -$77K | -$750K | -$954K | -$504K | |
| Non-Operating Interest Income | $3.55M | - | $509K | $222K | $166K | $164K |
| Non-Operating Interest Expense | - | - | $586K | $597K | $643K | $668K |
| Other Income/Expense | - | - | - | -$375K | -$477K | - |
Income Before Tax | $3.17M | -$50.93K | -$31.65M | -$38.61M | -$40.53M | -$22.31M |
Income Tax | - | - | - | - | - | - |
Net Income | $3.17M | -$50.93K | -$31.65M | -$38.61M | -$40.53M | -$22.31M |
Minority Interests | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - |
Net Income to Common | $3.17M | -$50.93K | -$31.65M | -$38.61M | -$40.53M | -$22.31M |
Shares Outstanding (Basic) | 55.7M | 46.5M | 71.23M | 70.84M | 70.11M | 69.89M |
Shares Outstanding (Diluted) | 55.7M | 46.5M | 71.23M | 70.84M | 70.11M | 69.89M |
EPS (Basic) | $0.06 | -$0.0011 | -$0.44 | -$0.55 | -$0.58 | -$0.32 |
EPS (Diluted) | $0.06 | -$0.0011 | -$0.44 | -$0.55 | -$0.58 | -$0.32 |
EBIT | -$373.67K | -$50.93K | - | - | - | - |
EBITDA | -$373.67K | -$50.93K | -$30.04M | -$36.99M | -$38.87M | -$20.64M |
